A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway. by Yang, Y et al.
RESEARCH ARTICLE Open Access
A long non-coding RNA, HOTAIR, promotes
cartilage degradation in osteoarthritis by
inhibiting WIF-1 expression and activating
Wnt pathway
Yang Yang1†, Dan Xing2†, Yawei Wang3, Haobo Jia1, Bing Li1 and Jiao Jiao Li4,5*
Abstract
Background: Long noncoding RNAs (lncRNAs) are recently found to be critical regulators of the epigenome.
However, our knowledge of their role in osteoarthritis (OA) development is limited. This study investigates the
mechanism by which HOTAIR, a key lncRNA with elevated expression in OA, affects OA disease progression.
Results: HOTAIR expression was greatly elevated in osteoarthritic compared to normal chondrocytes. Silencing and
over-expression of HOTAIR in SW1353 cells respectively reduced and increased the expression of genes associated
with cartilage degradation in OA. Investigation of molecular pathways revealed that HOTAIR acted directly on Wnt
inhibitory factor 1 (WIF-1) by increasing histone H3K27 trimethylation in the WIF-1 promoter, leading to WIF-1
repression that favours activation of the Wnt/β-catenin pathway.
Conclusions: Activation of Wnt/β-catenin signalling by HOTAIR through WIF-1 repression in osteoarthritic
chondrocytes increases catabolic gene expression and promotes cartilage degradation. This is the first study to
demonstrate a direct link between HOTAIR, WIF-1 and OA progression, which may be useful for future
investigations into disease biomarkers or therapeutic targets.
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Background
Osteoarthritis (OA) is a leading cause of chronic
disability worldwide, affecting over 50% of patients above
55–80 years of age [1]. Pain and reduced mobility in OA
patients bring much more than a drastic decline in qual-
ity of life, but also increased risk of premature death due
to cardiovascular disease, diabetes mellitus, obesity, and
cognitive disorders [2]. Unfortunately, OA has no cure
and current treatments can only relieve symptoms rather
than stop or reverse disease progression [3]. A major
hurdle preventing the development of effective, disease-
modifying treatments for OA is that a full understanding
of the pathological mechanisms contributing to OA pro-
gression has not been achieved. These likely involve a
multitude of complex and interrelated processes affect-
ing the entire joint, including articular cartilage, sub-
chondral bone, synovial tissue and the meniscus [4].
Increasing our understanding of OA pathogenesis may
be the key to identifying new disease biomarkers or
therapeutic targets to aid the treatment of OA.
The human genome is now known to comprise not
only protein-coding elements, which constitute only 2%
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of the total genetic material present, but also a large
amount of genetic material that transcribes multiple fam-
ilies of noncoding RNAs. Many of these noncoding RNAs
have been shown to modulate gene expression and have
structural, regulatory, or unknown functions [5]. There are
two major groups of noncoding RNAs based on their
length, short noncoding RNAs and long noncoding RNAs.
MicroRNAs are the most commonly studied short noncod-
ing RNAs with a range of roles in affecting cell fate and dis-
ease pathophysiology [6]. On the other hand, the role of
long noncoding RNAs (lncRNAs) as critical regulators of
biological processes, and their effects on tissue development
and disease has only begun to emerge within the last dec-
ade. LncRNAs are defined as transcripts > 200 nucleotides
in length, and are mostly produced by the same transcrip-
tional machinery as messenger RNAs (mRNAs) [7].
LncRNAs are now known to be differentially expressed in
many human diseases including metabolic, cardiovascular,
neurodegenerative and psychiatric diseases [8], as well as
cancer [9]. Although less well studied as in other tissues,
lncRNAs have been reported to play critical roles in the de-
velopment of bone and cartilage, and diseases associated
with these tissues [10]. A small number of recent reviews
have summarised the relation between lncRNAs and regu-
lation or pathogenesis of OA, including their roles in extra-
cellular matrix degradation, inflammation, chondrocyte and
synoviocyte apoptosis, and angiogenesis [11–14]. To date,
limited studies have revealed the regulatory roles of specific
lncRNAs in OA, including GAS5 [15], lncRNA-CIR [16],
and H19 [17] as the top candidates.
Thousands of lncRNAs are shown to be differentially
expressed between OA and normal cartilage obtained
from patients with knee OA [18]. Our previous study
also identified 121 up- or down-regulated lncRNAs in
OA compared with normal human cartilage, through
microarray analysis that was validated by RT-PCR [19].
From these, HOX antisense intergenic RNA (HOTAIR)
was identified as the lncRNA with the most upregulated
expression in OA samples (> 20 fold compared to nor-
mal samples). General over-expression of HOTAIR is
known to induce genome-wide targeting of polycomb
repressive complex 2 (PRC2), leading to altered methyla-
tion of histone H3 lysine 27 (H3K27) and changes in
gene expression [10]. Much evidence suggests that mis-
regulation of HOTAIR is associated with a variety of
cancers and cancer metastasis [20–23]. However, the
role of HOTAIR in rheumatic diseases is not well under-
stood, with some evidence suggesting that HOTAIR has
an important regulatory role in rheumatoid arthritis
[24], and that it promotes the expression of ADAMTS-5
and matrix metalloproteinases (MMPs) in osteoarthritic
chondrocytes [25, 26]. However, a clear link between the
regulatory role of HOTAIR and OA pathogenesis has
not been established.
The Wnt/β-catenin signalling pathway is an evolution-
arily conserved pathway with critical roles in tissue de-
velopment and maintenance [27]. In non-regenerating
organs such as the mammalian heart, this pathway is
quiescent but can be activated in response to injury [28].
A growing body of evidence suggests that this pathway
is involved in fibrotic processes as part of the imperfect
healing in these organs [27]. Similarly, aberrant activa-
tion of Wnt/β-catenin signalling has been linked to the
development of OA [29].
Wnt inhibitory factor 1 (WIF-1) is a key inhibitor of
the Wnt/β-catenin pathway. WIF-1 binds directly to
extracellular Wnt ligands, preventing their interaction
with cell surface receptors and hence leading to the deg-
radation of cytosolic β-catenin by the APC/Axin1 de-
struction complex [30]. Epigenetic silencing of WIF-1
was shown to be an important mechanism causing aber-
rant activation of the Wnt/β-catenin pathway in several
human cancers [31, 32]. Interestingly, altered HOTAIR
expression was shown to be involved in repressing the
transcription of WIF-1, thereby activating Wnt/β-ca-
tenin signalling in oesophageal squamous cell carcinoma
[33]. We therefore hypothesised that HOTAIR may pro-
mote the progression of OA through a similar axis, by
reducing WIF-1 expression and thus activating the Wnt/
β-catenin pathway. This is the first study to demonstrate
that the lncRNA HOTAIR directly inhibits WIF-1 ex-
pression by increasing histone H3K27 methylation in the
promoter region, leading to elevated Wnt/β-catenin sig-
nalling that promotes cartilage degradation in OA.
Results
Gene expression profile of chondrocytes from normal and
OA patients
OA-related gene expression levels were compared be-
tween chondrocytes isolated from knee cartilage of
normal and OA patients. OA chondrocytes showed sig-
nificantly higher HOTAIR expression than normal chon-
drocytes (Fig. 1a). The osteoarthritic phenotype of OA
chondrocytes was confirmed by their significantly ele-
vated expression of matrix degradation markers includ-
ing MMP-9, MMP-13, BMP-2 and ADAMTS5, as well
as reduced expression of COL2A1 which is a major
component of the cartilaginous matrix (Fig. 1b).
Effect of HOTAIR inhibition and over-expression on gene
expression in SW1353 cells
When HOTAIR function was inhibited in SW1353 cells
by siRNA-mediated knockdown of HOTAIR, the mRNA
expression of HOTAIR was significantly reduced in
these cells (Fig. 2a, left). Accompanying this was a sig-
nificant reduction in the expression of OA-related cata-
bolic genes MMP-13, ADAMTS5 and BMP-2, as well as
significant increase in the expression of cartilage-related
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anabolic genes TIMP3, ACAN and SOX9 (Fig. 2a, right)
compared to the negative control.
Conversely, SW1353 cells induced to over-express
HOTAIR by retrovirus infection showed significantly
higher mRNA expression of HOTAIR compared to the
vector control (Fig. 2b, left). This was accompanied by
gene expression changes opposite to those observed for
HOTAIR inhibition, that is, significant increase in the
expression of MMP-13, ADAMTS5 and BMP-2, as well
as significant decrease in the expression of TIMP3,
ACAN and SOX9 (Fig. 2b, right).
Effect of HOTAIR inhibition and over-expression on
protein expression in SW1353 cells
Western blot was used to examine the expression of
MMP-13, BMP-2, ADAMTS5 and SOX9 at the protein
Fig. 1 Expression levels of (a) HOTAIR and (b) OA-related genes in chondrocytes isolated from normal and OA cartilage (n= 10). Relative mRNA expression
is determined by real-time qRT-PCR and normalised to GAPDH. The OA group is expressed as a fold difference from the normal group. *P< 0.05
Fig. 2 Expression levels of HOTAIR, as well as OA- and cartilage-related genes in SW1353 cells at 48 h after (a) siRNA-mediated knockdown of
HOTAIR or (b) over-expression of HOTAIR by retrovirus infection. Relative mRNA expression is determined by real-time qRT-PCR and normalised to
GAPDH. The HOTAIR knockdown and over-expression groups are expressed as a fold difference from their respective controls. *P < 0.05
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level following HOTAIR knockdown (Fig. 3a) and
over-expression (Fig. 3b) in SW1353 cells. The
protein expression results aligned with changes in
gene expression, where inhibition of HOTAIR func-
tion reduced the expression of MMP-13, BMP-2 and
ADAMTS5 protein but increased the expression of
SOX9 protein (Fig. 3c-f). Meanwhile, over-expression
of HOTAIR in SW1353 cells resulted in opposite
changes in the expression of these same proteins
(Fig. 3c-f).
Fig. 3 Western blot analysis of OA- and cartilage-related protein expression in SW1353 cells at 48 h after (a) siRNA-mediated knockdown of
HOTAIR or (b) over-expression of HOTAIR by retrovirus infection. Protein expression levels of (c) MMP-13, (d) BMP-2, (e) ADAMTS5 and (f) SOX9
are measured by densitometry analysis. The HOTAIR knockdown and over-expression groups are expressed as a fold difference from their
respective controls *P < 0.05
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HOTAIR regulation of WIF-1 expression
To determine the mechanism by which HOTAIR regu-
lates the expression of genes associated with cartilage ca-
tabolism and anabolism in OA, we investigated WIF-1
due to its known interactions with HOTAIR in cancer
progression. WIF-1 mRNA and protein expression were
both greatly elevated in SW1353 cells following siRNA
knockdown of HOTAIR (Fig. 4a). Conversely, HOTAIR
over-expression in SW1353 cells caused significant
reduction in mRNA and protein expression of WIF-1
(Fig. 4b). The inverse relation between HOTAIR and
WIF-1 expression was further confirmed through a dual
luciferase reporter assay. When transfected with a vector
containing the WIF-1 promoter region, SW1353 cells
over-expressing HOTAIR showed significant inhibition
of luciferase activity compared to control cells (Fig. 4c).
The regulatory mechanism by which HOTAIR modu-
lates WIF-1 expression was investigated by measuring
the levels of histone H3K27 trimethylation in SW1353
cells over-expressing HOTAIR. A schematic illustrates
targeted primer locations in the WIF-1 gene (Fig. 4d). A
chromatin immunoprecipitation (ChIP) assay was used
to quantify enrichment of H3K27 in the WIF-1 pro-
moter, which showed a significant increase in H3K27 tri-
methylation in SW1353 cells over-expressing HOTAIR
compared to control cells (Fig. 4e).
Effects of HOTAIR on Wnt/β-catenin signalling pathway
Since WIF-1 is a key regulator of the Wnt/β-catenin
pathway, we proceeded to investigate the effects of
HOTAIR expression on Wnt/β-catenin signalling. In
SW1353 cells over-expressing HOTAIR, β-catenin con-
centration was increased in the nucleus and reduced in
the cytoplasm compared to control cells (Fig. 5a). Fur-
thermore, the expression levels of c-Myc, ZEB1 and
SNAIL as downstream target genes of Wnt/β-catenin
signalling were all significantly increased in SW1353
cells over-expressing HOTAIR (Fig. 5b). These results
collectively suggested that HOTAIR expression led to
accumulation of β-catenin in the cell nucleus and hence
activation of the canonical Wnt/β-catenin pathway. The
proposed mechanism by which HOTAIR expression af-
fects Wnt/β-catenin signalling in OA development is
summarised in a schematic (Fig. 5c).
Discussion
The pathogenesis of OA involves many complex and in-
terrelated processes that result in local inflammation
and degenerative changes in all tissue types within the
joint [34, 35]. Structural degradation of the extracellular
matrix in key joint tissues, in particular the articular car-
tilage, is a hallmark of OA progression and is closely re-
lated to altered gene expression in chondrocytes and
other cells [36]. Over the last decade, studies examining
novel pathways in OA pathogenesis have pointed to the
important role of epigenetic mechanisms in modulating
cell phenotype and gene expression in OA [37–39]. In
particular, various microRNAs are now understood to
have critical roles in maintaining cartilage homeostasis
and have altered expression either as a cause or conse-
quence of OA [38, 40]. However, the roles of lncRNAs
in OA pathogenesis are much less well understood.
LncRNAs are now being increasingly studied due to
growing evidence pointing to their roles in chromatin
modification and transcriptional regulation, leading to
diverse biological effects including cell cycle regulation,
immune surveillance, and cell pluripotency [41]. Al-
though some studies including our own have revealed
key lncRNAs associated with OA development [18, 19],
much work remains to be done in elucidating the spe-
cific regulatory roles of these lncRNAs in OA and the
molecular mechanisms involved. This is the first study
to show that HOTAIR, one of the most highly upregu-
lated lncRNAs in osteoarthritic chondrocytes [19], acts
directly on WIF-1 to modulate the Wnt/β-catenin path-
way in OA and provide new insight into its pathophysio-
logical functions.
To understand the link between HOTAIR and OA-
related gene expression, we studied the effects of
HOTAIR silencing and over-expression in chondrocytes
by using SW1353 cells as an established chondrocytic
cell model and a reliable transfection host [42]. Although
SW1353 is a chondrosarcoma cell line, the cells exhibit
similar responses as primary chondrocytes to a variety of
catabolic cytokines relevant to OA, and have been used
as the cell line of choice in many studies to investigate
the molecular mechanisms of OA pathogenesis [43–45].
We found that HOTAIR over-expression in SW1353
cells matched the expression profile of OA-related genes
in human primary osteoarthritic chondrocytes, charac-
terised by the upregulation of catabolic enzymes (MMP-
13, ADAMTS5) and cartilage repair markers (BMP-2),
and downregulation of anabolic markers (TIMP3, SOX9)
and cartilage matrix proteins (ACAN). Conversely, silen-
cing of HOTAIR in SW1353 cells resulted in opposite
trends in OA-related gene and protein expression. These
findings suggested an essential role of HOTAIR in regu-
lating cartilage homeostasis by controlling the expres-
sion of key genes and proteins involved in cartilage
degradation and restoration.
The roles of WIF-1 in skeletal tissue development have
been investigated in other studies. WIF-1 is shown to be
a multifunctional modulator of signalling pathways in
cartilage development [46, 47], and has differential ex-
pression during neonatal and pre-adolescent develop-
ment in chondrocytes surrounding cartilage canals and
the osteochondral junction [48]. Moreover, WIF-1 is
shown to have a protective effect against cartilage
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degradation in experimental arthritis, and has important
effects in promoting the balance of cartilage and bone
turnover [49]. Although WIF-1 expression levels in ar-
ticular cartilage are negatively correlated with disease se-
verity in patients with knee OA [50], the mechanisms by
which WIF-1 is regulated during OA development have
not been previously investigated.
Epigenetic disruptions, some of which lead to gene si-
lencing through methylation of CpG sites in the pro-
moter region and histone modification of genes, have
been identified as key events in OA development [37].
However, the upstream and downstream mechanisms
associated with these aberrant disruptions remain un-
clear in the majority of OA-related pathways. In this
Fig. 4 The inverse relation between HOTAIR and WIF-1 expression is demonstrated by WIF-1 mRNA and protein expression in SW1353 cells at 48 h
after (a) siRNA-mediated knockdown of HOTAIR or (b) over-expression of HOTAIR by retrovirus infection, as well as by (c) a dual luciferase reporter
assay at 36 h after transfecting HOTAIR over-expressing or control SW1353 cells with a vector containing the WIF-1 promoter. The HOTAIR knockdown
and over-expression groups are expressed as a fold difference from their respective controls. (d) Schematic illustrating primer locations in the WIF-1
promoter. (e) ChIP assay showing enrichment of H3K27 at the WIF-1 promoter. The PCR products were analysed by gel electrophoresis. *P < 0.05
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study, we found that HOTAIR over-expression reduced
WIF-1 gene and protein expression by increasing its his-
tone H3K27 methylation in the promoter region, which
promoted the activation of the Wnt/β-catenin pathway.
This regulatory mechanism was similar to an axis that
contributed to metastasis in oesophageal squamous cell
carcinoma [33]. Moreover, it was reported that HOTAIR
could bind PRC2 to reprogram the chromatin state,
thereby regulating the expression of hundreds of genes
to promote cancer metastasis [21, 22]. The PRC2 com-
plex is one of the two classes of polycomb-group pro-
teins (PcG) that lead to transcriptional repression by
catalysing H3K27 trimethylation [51]. Based on the find-
ings of this study, we propose that HOTAIR may bind
with PRC2 to induce histone H3K27 trimethylation in
the WIF-1 promoter, which inhibits WIF-1 expression.
This leads to increased activation of Wnt/β-catenin sig-
nalling that is associated with the progression of OA by
inducing excessive cartilage remodelling and degradation
[52]. The direct interaction of HOTAIR with the PRC2
complex in this axis needs to be confirmed in human
articular chondrocytes, as well as possible interactions
relating to H3K27 methylation (such as H3K4 modifica-
tions) [53]. The upstream regulatory mechanisms of
HOTAIR expression in OA also need to be determined,
which may involve interactions with other lncRNAs
[54] or mechanoresponsive pathways [55]. Further-
more, histone methylation is known to be affected by
inhibitors of DNA methylation, such as 5-Aza-2′-
deoxycytidine which is used as an anti-cancer drug
[56, 57], and it would be interesting to investigate the
effects of applying such compounds on HOTAIR sig-
nalling in OA. These additional findings building on
the results of this study will confirm our proposed
mechanism, and potentially improve the accuracy of
predictive models for the pathogenesis of cartilage
damage in OA [58]. Further studies demonstrating
the interactions of HOTAIR and WIF-1 in normal
and OA human cartilage explants, and physiologically
relevant in vivo models of OA need to be performed
for this pathway to be used as a target for biomarker
or therapeutic development.
Fig. 5 a β-catenin protein expression in the whole cell, nucleus and cytoplasm of SW1353 cells at 48 h after over-expression of HOTAIR by
retrovirus infection compared to control cells. Histone-H3 was used as a nuclear protein control and GAPDH as a cytoplasmic protein control. b
Expression levels of c-Myc, ZEB1 and SNAIL as downstream targets of β-catenin signalling in SW1353 cells over-expressing HOTAIR and controls. c
Schematic of the proposed mechanism by which HOTAIR contributes to cartilage degradation in OA
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There were a few limitations in our study. First, al-
though their gene expression results were presented,
TIMP3 and ACAN protein expression could not be ob-
tained in the HOTAIR knockdown and over-expression
experiments as their levels were very low in both the
control and test groups, which prevented the extraction
of reliable results to perform data analysis. Second, the
enrichment of H3K27me3 in the WIF-1 promoter region
of HOTAIR over-expressing cells as demonstrated in the
ChIP assay was not able to be confirmed by Western
blot due to low protein expression. Last, c-Myc, ZEB1
and SNAIL mRNA were selected for pathway analysis as
downstream targets of β-catenin signalling, as these
genes were likely to respond with rapid and significant
changes in expression, but other potentially suitable tar-
gets exist such as cyclin D1. The protein expression of
c-Myc, ZEB1 and SNAIL in whole cell lysate was not
verified by Western blot as their expression levels were
expected to be low or unreliable, and much less sensitive
to change compared to mRNA.
Conclusions
This study has defined a clear link between the expres-
sion of the lncRNA HOTAIR and OA development,
through its actions on WIF-1 that lead to changes in
Wnt/β-catenin signalling. This is the first study to dem-
onstrate that in osteoarthritic cartilage, elevated
HOTAIR expression leads to silencing of WIF-1 through
H3K27 methylation in the WIF-1 promoter region. Our
study provides new evidence for the regulatory role of
HOTAIR in OA pathogenesis, which will be useful for
future studies investigating the epigenetics of OA and
finding effective disease biomarkers or therapeutic
targets.
Methods
Tissue samples and chondrocyte isolation
This research was approved by the Ethics Committee of
Tianjin Hospital, China (2014–008). Discarded cartilage
tissues were obtained from 10 normal patients (without
OA) undergoing traumatic above-knee amputation and
10 OA patients undergoing total knee replacement sur-
gery, aged 47–78 years. The OA patients were clinically
diagnosed to be Kellgren-Lawrence grade 3 based on
radiographic examination. All clinical specimens were
obtained after patients gave informed consent. The two
groups were paired and cartilage samples were matched
by age, sex and body mass index.
Chondrocytes were isolated from the articular cartilage
of clinical specimens obtained from normal and OA pa-
tients. Cartilage samples were minced and digested in
0.15% (w/v) collagenase (CLS-2, Worthington, USA) for
16 h at 37 °C, in medium consisting of Dulbecco’s Modi-
fied Eagle Medium (DMEM, Gibco, UK) supplemented
with 10% fetal bovine serum (FBS, HyClone, USA), 100
U/mL penicillin (Gibco) and 100 μg/mL streptomycin
(Gibco). Isolated chondrocytes were washed in PBS and
filtered through a 100 μm cell strainer (BD Biosciences,
USA). The cells were seeded at high density (1 × 104
cells/cm2) and kept in maintenance medium for 2 days
prior to gene expression analysis.
SW1353 cell culture and transfection
Human chondrosarcoma cells (SW1353) were obtained
from the American Type Culture Collection (ATCC).
Cells were grown in maintenance medium consisting of
DMEM supplemented with 10% FBS at 37 °C with 5%
CO2.
To silence HOTAIR function, SW1353 cells were
transfected with small interfering RNA (siRNA) oligonu-
cleotides targeting HOTAIR or the negative control (50
nM), using Lipofectamine™ RNAiMAX (Invitrogen,
USA) according to the manufacturer’s instructions. The
gene-specific siRNA is siHOTAIR (5′-GAACGGGAGU
ACAGAGAGAUU-3′). Transfected cells were kept in
maintenance medium for 48 h prior to further analyses.
To overexpress HOTAIR in SW1353 cells, a HOTAIR
expression retrovirus vector was constructed. Full-length
HOTAIR was amplified by PCR and cloned into the
pBABE retroviral vector (Cell Biolabs, USA) using the
primers 5′-GACTCGCCTGTGCTCTGGAGCT-3′ and
5′-TTGAAAATGCATCCAGATTTTT-3′. SW1353 cells
were infected with retrovirus containing HOTAIR or
negative control (vector) in the presence of 10 μg/mL
polybrene (Sigma-Aldrich, USA). The supernatant was
removed after 24 h and replaced with maintenance
medium containing 1 μg/mL puromycin. Cells were cul-
tured for 48 h prior to further analyses.
Analyses of HOTAIR-overexpressing SW1353 cells
A chromatin immunoprecipitation (ChIP) assay was
conducted for SW1353-Vector and SW1353-HOTAIR
cells by Tianjin Zhongrui Biotechnology Co. Ltd., using
EZ-ChIP™ (catalogue number 17–371; Sigma-Aldrich,
USA) according to the manufacturer’s instructions.
Briefly, sheared crosslinked chromatin was immunopre-
cipitated with anti-H3K27me3 antibody (catalogue num-
ber 07–449, Sigma-Aldrich) and normal rabbit IgG
(catalogue number 12–370, Sigma-Aldrich). After chro-
matin immunoprecipitation, retrieved DNA was detected
by standard end-point PCR. The PCR products were
analysed by gel electrophoresis and quantitated using
GelAnalyzer. Primers for the WIF-1 promoter region are
designed according to published methods [59], and the
sequences are listed in Supplementary Table 1.
The nuclear and cytoplasmic protein fractions were
extracted from SW1353-Vector and SW1353-HOTAIR
cells using the NE-PER™ Nuclear and Cytoplasmic
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Extraction Kit (catalogue number 78833; Thermo Fisher
Scientific, USA) according to the manufacturer’s instruc-
tions. Proteins were detected by Western blot analysis.
Dual luciferase reporter assay
pGL3-WIF1 Promoter was constructed by inserting PCR
product containing 1205 bp in the 5′-flanking sequence
of the human WIF-1 promoter into the pGL3-basic vec-
tor. Together with 40 ng pRL-TK Vector (Promega,
USA) containing Renilla luciferase as an internal control,
200 ng pGL3-WIF1 Promoter were transfected into
SW1353-Vector and SW1353-HOTAIR cells using
Lipofectamine™ 2000 (Invitrogen, USA) according to the
manufacturer’s instructions. Transfected cells were cul-
tured in maintenance medium, and luciferase reporter
assays were performed 36 h after transfection. Cells were
lysed and the firefly and Renilla luciferase activities in
each well were measured using the Dual Luciferase Re-
porter Assay System (Promega). All measured luciferase
activities were normalised to pRL-TK Vector activity,
and firefly luciferase activity was normalised to Renilla
luciferase activity for each well.
Gene expression analysis
Total RNA was isolated from cells using the TRIzol re-
agent (Invitrogen) according to the manufacturer’s in-
structions. Briefly, samples were homogenised using the
TRIzol reagent and chloroform was added, after which
RNA was precipitated using isopropanol. The RNA was
resuspended in 20 μL purified water.
Reverse transcription into cDNA was performed using
1 μg total RNA from each sample using PrimeScript RT
reagent Kit with gDNA Eraser (Takara Bio, USA) ac-
cording to the manufacturer’s instructions. Gene expres-
sion levels were quantified with SYBR Premix Ex TaqII
kit (Takara Bio) using a 7900HT Fast Real-Time PCR
System (Applied Biosystems, USA) and normalised to
GAPDH. Primer sequences were purchased from Sigma-
Aldrich and listed in Supplementary Table 1. Relative
gene expression was calculated using the comparative Ct
(2−ΔΔCT) method.
Western blotting
Cells were lysed using a cell lysis buffer (Beyotime,
China), and protein content was quantified using a BCA
assay (Thermo Fisher Scientific). Equal amount of pro-
tein from each sample was electrophoresed on 10% (w/
v) SDS-PAGE and transferred to PVDF membranes
(EMD Millipore). The membranes were blocked with 5%
milk in TBST for 1 h at room temperature, and incu-
bated at 4 °C overnight with primary antibodies against
WIF-1 (catalogue number sc-373780; Santa Cruz Bio-
technology, USA), β-catenin (catalogue number C7082;
Sigma-Aldrich), and GAPDH (catalogue number 5174;
CST, China) at 1/1000 dilution. Membranes were
washed three times for 10 min each with TBST, and
then incubated for 1 h at room temperature with sec-
ondary antibody conjugated to horseradish peroxidase
(HRP) at 1/5000 dilution (anti-rabbit IgG, CST). The
blots were visualised using enhanced chemiluminescence
reagent (ECL, Thermo Fisher Scientific, USA). The blot
intensity was quantified using molecular imaging soft-
ware (Carestream Health, USA) after normalising to the
corresponding loading control.
Statistical analysis
Data for all experiments were obtained from at least
three independent samples, and all results were
expressed as mean ± standard deviation. Statistical ana-
lysis was performed using the Stata 12.0 statistical soft-
ware package (StataCorp, USA). One-way ANOVA with
Tukey’s multiple comparisons test was used for statis-
tical comparisons. A P-value of 0.05 was considered sta-
tistically significant.
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